ASH 2019 updates on Minimal Residual Disease (MRD) – Myeloma Patients Europe

Minimal Residual Disease (MRD) is one of the big topics in myeloma. Different techniques to measure MRD and new data about its role in predicting the risk of relapse are some of the topics discussed during the American Society of Hematology (ASH) Annual Meeting. In this video Dr Francesca Gay, University of Torino, Italy, explains …

Read the full article here

Related Articles